BofA lowered the firm’s price target on Clorox (CLX) to $145 from $150 and keeps a Neutral rating on the shares. The firm lowered its FY25 adjusted EPS forecast to $6.99 from $7.14 following the fiscal Q3 miss and tempered FY26 estimates on softer top line forecasts due to the ERP impact, the analyst tells investors in a post-earnings note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
- Clorox price target lowered to $144 from $151 at JPMorgan
- Clorox’s Financial Outlook: Hold Rating Amid Sales Guidance Revision and Market Challenges
- Clorox price target lowered to $142 from $145 at Wells Fargo
- Clorox Reports Q3 2025 Results Amid Sales Decline
- Closing Bell Movers: Palantir falls 9%, Ford down 2% on earnings